| Sweden n = 9 | Finland n = 14 | The NL n = 33 | Germany n = 51 | Estonia n = 22 | Francea n = 0 | Spain n = 28 | The UK n = 13 |
---|---|---|---|---|---|---|---|---|
Persons with DNOS, n (%), (total n = 170) | 9 (5) | 14 (8) | 33 (19) | 51 (30) | 22 (13) | – | 28 (17) | 13 (8) |
 Age, years; mean (SD) | 84 (3) | 85 (7) | 85 (6) | 85 (7) | 83 (7) | – | 86 (8) | 86 (7) |
 Gender, female (%) | 6 (67) | 8 (57) | 28 (85) | 34 (67) | 18 (82) | – | 23 (81) | 10 (77) |
 Symptoms, years, mean (SD) | 2.2 (1.5) | 5.0 (2.4) | 3.7 (2.6) | 3.5 (3.1) | 5.4 (6.8) | – | 3.9 (4.6) | 3.4 (2.9) |
Comorbidity (CCI), 0–37, mean, (SD) | 1.9 (0.8) | 3.3 (2.7) | 2.2 (1.4) | 2.8 (1.6) | 2.7 (1.4) | – | 2.0 (1.7) | 2.1 (0.9) |
Cognitive function (SMMSE), 0–30 | 13 (6) | 16 (6) | 10 (5) | 14 (6) | 10 (7) | – | 12 (3) | 13 (8) |
Quality of life (QoL-AD), 13–52 | 37 (3) | 29 (5) | 35 (7) | 34 (4) | 27 (5) | – | 30 (6) | 34 (5) |
Activities of daily living (Katz ADL), 0–6 | 3 (1) | 2 (2) | 2 (1) | 2 (1) | 2 (2) | – | 1 (1) | 3 (2) |
Depression (CSDD), 0–38, mean, (SD) | 5 (4) | 0 (0) | 5 (5) | 8 (5) | 5 (4) | – | 5 (4) | 5 (3) |
Resource utilisation (RUD) last 30 days, % |  |  |  |  |  | – |  |  |
 Hospital admission, geriatric ward | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 |
 Visit general practitioner | 3 (34) | 11 (79) | 4 (12) | 38 (75) | 5 (23) | – | 8 (29) | 4 (31) |
 Visit geriatrician | 1 (11) | 1 (7) | 1 (3) | 0 | 0 | – | 14 (50) | 0 |
 Visit neurologist | 0 | 0 | 0 | 26 (51) | 0 | – | 4 (14) | 0 |
 Visit psychiatrist | 0 | 0 | 0 | 0 | 5 (23) | – | 2 (7) | 1 (8) |
Neuropsychiatric symptoms (NPI-Q) |  |  |  |  |  | – |  |  |
 Severity, 0–36 | 5 (7) | 4 (4) | 7 (6) | 7 (6) | 5 (5) | – | 6 (6) | 6 (4) |
Psychotropics, use of yes/no, n (%) | 7 (78) | 9 (64) | 24 (73) | 35 (69) | 13 (59) | – | 24 (86) | 10 (77) |
 Antipsychotics | 1 (11) | 2 (14) | 16 (49) | 19 (37) | 10 (46) | – | 16 (57) | 4 (31) |
 Anxiolytic | 2 (22) | 3 (21) | 5 (15) | 5 (10) | 1 (5) | – | 9 (32) | 0 |
 Sedatives | 2 (22) | 5 (36) | 6 (18) | 3 (6) | 1 (5) | – | 7 (25) | 0 |
 Antidepressants | 3 (33) | 4 (29) | 9 (27) | 10 (20) | 1 (5) | – | 11 (39) | 6 (46) |
 Antidementia | 3 (33) | 2 (14) | 10 (30) | 17 (33) | 1 (5) | – | 2 (7) | 2 (15) |